Hello Afib!!!

Quote


Anonymous said:
Time for the happy dance. Time for the celebration.
Click to expand...

Comming at ya AFib with a black box for death once you stop taking the drug - better hope patients on xzarelto don't need a tooth extraction, colonoscopy, or procedure, because if they stop taking it they will regret it. At least you can have dialysis to clear it out of your system - oh wait you CAN'T!
 
Anonymous said:
Comming at ya AFib with a black box for death once you stop taking the drug - better hope patients on xzarelto don't need a tooth extraction, colonoscopy, or procedure, because if they stop taking it they will regret it. At least you can have dialysis to clear it out of your system - oh wait you CAN'T!
Click to expand...


""HATER IN THE HOUSE'!!
 
Anonymous said:
..same ones that would write a product that causes GI Bleed...**shrugs**....
Click to expand...

From FDA's website
__________________________
FDA NEWS RELEASE

For Immediate Release: Nov. 4, 2011
Media Inquiries: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

...

In that trial, Xarelto’s risk of major bleeding was similar to that of warfarin; however, it caused less bleeding into the brain and more bleeding into the stomach and intestines.

...

_________________________
 
Dont get too excited. Per protocol data nowhere to be found in the PI. They stuck in the ITT data that is less favorable.

The FDA did this to throw Nissen a bone since he did everything he could to stop Xarelto.......but did not succeed.

Margaritas in D.C. regards.......
 
Anonymous said:
Dont get too excited. Per protocol data nowhere to be found in the PI. They stuck in the ITT data that is less favorable.

The FDA did this to throw Nissen a bone since he did everything he could to stop Xarelto.......but did not succeed.

Margaritas in D.C. regards.......
Click to expand...

Wish Nissen had the clout to get his point across the money grubbing other members if the committee and end thus dangerous drug from being released.
 
Anonymous said:
..same ones that would write a product that causes GI Bleed...**shrugs**....
Click to expand...

Or the same one's who prescribe Warfarin? Because we all know how clean that molecule is. Or how about the ACS market? You think cardiologists put much effort into anti-platelet prescribing which is rampant with black-box warnings?
 
Anonymous said:
Wish Nissen had the clout to get his point across the money grubbing other members if the committee and end thus dangerous drug from being released.
Click to expand...

Oh, it's so dangerous isn't it, see what happens when you drink the BI kool-aid for months on end? I mean, it's so dangerous that the 1,000,000+ patients who have already been taking it in the European market must SURELY be on their death beds. Right? Makes sense. Such a dangerous drug.
 
Anonymous said:
Oh, it's so dangerous isn't it, see what happens when you drink the BI kool-aid for months on end? I mean, it's so dangerous that the 1,000,000+ patients who have already been taking it in the European market must SURELY be on their death beds. Right? Makes sense. Such a dangerous drug.
Click to expand...

In EU they only take the drug for 10 days or 35 days. Short term risk is way different than placing a patient on your dangerous drug for a lifetime. Stop thinking about your greedy bonus for a minute and realize your drug can cause fatalities.
 
Anonymous said:
Or the same one's who prescribe Warfarin? Because we all know how clean that molecule is. Or how about the ACS market? You think cardiologists put much effort into anti-platelet prescribing which is rampant with black-box warnings?
Click to expand...

Just because you found an article from an investor that thinks your drug will be used in ACS doesn't mean it ever will be. The bleed risks goes up and if you think DR. Nissen had a problem with your AFib faraday just wait till he gets a mouth-hold on your ACS data which was only marginal at best.
 
Anonymous said:
Or the same one's who prescribe Warfarin? Because we all know how clean that molecule is. Or how about the ACS market? You think cardiologists put much effort into anti-platelet prescribing which is rampant with black-box warnings?
Click to expand...

No way in he'll this dangerous drug will get approved for ACS, the data was only marginal at best and downright full of FATAL bleed outs in the least. This drug is a dog and it's howling fir someone to humanely put it down.
 
Anonymous said:
No way in he'll this dangerous drug will get approved for ACS, the data was only marginal at best and downright full of FATAL bleed outs in the least. This drug is a dog and it's howling fir someone to humanely put it down.
Click to expand...

Ha, riiiigggggght...just like "no way in hell" this drug was ever going to get approved for SPAF. Man you guys whine like a bunch of paranoid BI-tches. Chill out and go sell your drug. Nobody takes a drug rep's opinion seriously anyway.
 
Anonymous said:
Ha, riiiigggggght...just like "no way in hell" this drug was ever going to get approved for SPAF. Man you guys whine like a bunch of paranoid BI-tches. Chill out and go sell your drug. Nobody takes a drug rep's opinion seriously anyway.
Click to expand...

SPAF data-set is way different than ACS data-set. To generalize one from the other is bogus logic pal. Go wiki logic to get some learnin.
 
Anonymous said:
Just because you found an article from an investor that thinks your drug will be used in ACS doesn't mean it ever will be. The bleed risks goes up and if you think DR. Nissen had a problem with your AFib faraday just wait till he gets a mouth-hold on your ACS data which was only marginal at best.
Click to expand...

A mouth-hold? You're quite the wordsmith. Do you have a lot of experience with Dr. Hidden and his mouth-hold technique?
 


Write your reply...
Top Bottom
Back
Quote